| Literature DB >> 10208580 |
S T Chen1, A Jen, S M Gentleman, L S Jen.
Abstract
The pattern of immunoreactivity for amyloid precursor (APP) and B-cell lymphoma protooncogene (Bcl-2) proteins in the rat retina was studied after intravitreal injection of basic fibroblast growth factor (bFGF) or transforming growth factor-beta (TGFbeta). In normal control retinas, intense immunostaining of APP and Bcl-2 was observed primarily in the endfeet and proximal part of radial processes of Müller glial cells. A dose-dependent reduction in immunostaining of APP and Bcl-2 in Müller cells was observed after injection of bFGF and TGFbeta. These results provide the first evidence that APP and Bcl-2 can be down-regulated by cytokines in vivo.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10208580 DOI: 10.1097/00001756-199902250-00012
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837